• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov15
Forte Biosciences released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.9937 (forecast USD -1.0266)
04:00
Forte Biosciences released FY2025 9 Months Earnings on November 14, 2025 (EST) with actual revenue of USD 0 and EPS of USD -3.325
04:00
Nov14
Forte Biosciences Reports Q3 2025 Earnings and Advances FB102 Clinical Development
14:07
Aug15
Forte Biosciences released FY2025 Q2 earnings on August 14 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -0.9578 (forecast USD -0.9966)
03:00
Forte Biosciences released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -2.3249
03:00
May16
Forte Biosciences released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.3734 (forecast USD -0.95)
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -17.68 M, EPS -0.9937

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -11.25 M, EPS -0.9578

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -15.66 M, EPS -1.3734

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More